2-96143592-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004418.4(DUSP2):​c.*231A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.56 in 577,316 control chromosomes in the GnomAD database, including 92,609 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 22089 hom., cov: 32)
Exomes 𝑓: 0.57 ( 70520 hom. )

Consequence

DUSP2
NM_004418.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.338

Publications

27 publications found
Variant links:
Genes affected
DUSP2 (HGNC:3068): (dual specificity phosphatase 2) The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product inactivates ERK1 and ERK2, is predominantly expressed in hematopoietic tissues, and is localized in the nucleus. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.776 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004418.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DUSP2
NM_004418.4
MANE Select
c.*231A>G
3_prime_UTR
Exon 4 of 4NP_004409.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DUSP2
ENST00000288943.5
TSL:1 MANE Select
c.*231A>G
3_prime_UTR
Exon 4 of 4ENSP00000288943.4
DUSP2
ENST00000718436.1
c.*231A>G
3_prime_UTR
Exon 4 of 4ENSP00000520821.1
DUSP2
ENST00000488952.1
TSL:2
n.*137A>G
downstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.532
AC:
80705
AN:
151780
Hom.:
22049
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.411
Gnomad AMI
AF:
0.660
Gnomad AMR
AF:
0.577
Gnomad ASJ
AF:
0.462
Gnomad EAS
AF:
0.797
Gnomad SAS
AF:
0.522
Gnomad FIN
AF:
0.652
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.559
Gnomad OTH
AF:
0.544
GnomAD4 exome
AF:
0.569
AC:
242237
AN:
425418
Hom.:
70520
Cov.:
4
AF XY:
0.566
AC XY:
126113
AN XY:
222656
show subpopulations
African (AFR)
AF:
0.410
AC:
4913
AN:
11974
American (AMR)
AF:
0.616
AC:
10501
AN:
17058
Ashkenazi Jewish (ASJ)
AF:
0.461
AC:
5988
AN:
12990
East Asian (EAS)
AF:
0.753
AC:
21690
AN:
28796
South Asian (SAS)
AF:
0.524
AC:
22711
AN:
43350
European-Finnish (FIN)
AF:
0.652
AC:
18017
AN:
27642
Middle Eastern (MID)
AF:
0.512
AC:
943
AN:
1840
European-Non Finnish (NFE)
AF:
0.559
AC:
143855
AN:
257344
Other (OTH)
AF:
0.558
AC:
13619
AN:
24424
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
4821
9642
14464
19285
24106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.532
AC:
80797
AN:
151898
Hom.:
22089
Cov.:
32
AF XY:
0.538
AC XY:
39946
AN XY:
74220
show subpopulations
African (AFR)
AF:
0.411
AC:
17013
AN:
41382
American (AMR)
AF:
0.578
AC:
8821
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.462
AC:
1601
AN:
3466
East Asian (EAS)
AF:
0.797
AC:
4091
AN:
5136
South Asian (SAS)
AF:
0.522
AC:
2515
AN:
4814
European-Finnish (FIN)
AF:
0.652
AC:
6879
AN:
10558
Middle Eastern (MID)
AF:
0.435
AC:
127
AN:
292
European-Non Finnish (NFE)
AF:
0.559
AC:
38002
AN:
67962
Other (OTH)
AF:
0.545
AC:
1147
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1953
3906
5860
7813
9766
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.548
Hom.:
72030
Bravo
AF:
0.526
Asia WGS
AF:
0.584
AC:
2032
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
7.0
DANN
Benign
0.39
PhyloP100
-0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1724120; hg19: chr2-96809331; API